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BACKGROUND Paravalvular regurgitation (PAR) remains a serious
complication after Transcatheter aortic valve replacement (TAVR).
Multidetector computed tomography (MDCT) based measurements of
the aortic basal virtual ring (BVR) are considered the gold standard for
trans-catheter heart valve (THV) sizing. However, the real anatomic
aortic annulus is a 3-dimensional structure. Aim: To compare mea-
surement of 3D-Anatomic Annulus with BVR and secondly to assess
independent predictive parameters that may impact on PAR > mild
post TAVR (PARþ).
METHODS MDCT was performed in 92 patients before and after
balloon or self-expandable TAVR. 3D-AAA shape was obtained point-
by-point following the semilunar attachment of aortic cusps (Osirix
MD 2.8.2). 3D-Oversizing index (nominal THV area/3D-AA area-1) x100
was calculated as well as 2D-Oversizing Index using BVR area instead
of 3D-AA area. PAR was quantiﬁed by planimetry of vena-contracta in
transthoracic echocardiography short axis view. Valvular calcium
volume and annulus calcium area were measured using Hounsﬁeld-
intensity detection. ROC Curves and logistic regression for PAR(þ)
were performed.RESULTS BVR area overall underestimated 3D-AA area by 199%
(p<0.001), signiﬁcantly more in PAR(þ) (267 %) versus PAR(-)
(179%, p<0.001). 3D-Oversizing Index had greater predictive value
for PAR>mild (AUC¼0.88) with 88% sensibility (Se) and 82% speci-
ﬁcity (Sp) than 2D-Oversizing index (AUC¼0.68) with 84% Se, but only
41% Sp (p<0.0001). Also, valvular calcium volume and annulus cal-
cium area were less predictors for PAR>mild (AUC¼0.68, respectively
AUC¼0.75, p¼0.002). In a Multivariate analysis, only 3D-Oversizing
Index showed an independent value for PAR>mild (OR¼18.6,
p<0.001). BVR area systole-diastole varies signiﬁcantly which implies
limitation for 2D annulus sizing. 3D-annulus showed no signiﬁcant
changing throughout the cardiac cycle.Variable AUC for PAR>mild p Value Cutoff Se Sp PPV NPV3D-Oversizing Index 0.88 (0.81-0.94) - 0% 88% 82% 65% 95%2D-Oversizing Index 0.68 (0.56-0.78) 0.0001 25% 84% 41% 36% 93%Delta (3D AAA/BVR) 0.82 (0.73-0.91) 0.2 21% 84% 73% 54% 92%Annulus Calcium Area 0.75 (0.66-0.85) 0.047 14mm2 87% 61% 45% 93%Valve Calcium Volume 0.68 (0.56-0.79) 0.002 150mm3 84% 55% 41% 90%CONCLUSIONS Basal ring CT measurement signiﬁcantly under-
estimated the real 3D Anatomic Aortic Annulus area. This may impact
on THV sizing and PAR incidence. 3D-Oversizing Index is the most
predictive factor for PAR>mild.
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BACKGROUND A certain degree of transcatheter heart valve(THV) over-
sizing is considered to be important to prevent signiﬁcant paravalvular
leakageafter transcatheter aortic valve replacement(TAVR).However, data
on the degree of oversizing and its impact on clinical outcomes are limited.
The objective of this analysis was to study the effect of the degree of
oversizing on clinical outcomes in theCHOICE randomized trial comparing
balloon-expandable(BE) and self-expanding(SE) valves.
METHODS The multicenter CHOICE trial randomized 241 high surgical
risk aortic stenosis patients in a 1:1 fashion to receive either a
BE(Edwards Sapien XT) or a SE(Medtronic CoreValve) THV, primary
endpoint being Valve Academic Research Consortium deﬁned rate of
device success. 178 patients in this trial had 3D multidetector CT data
for degree of device oversizing and were included in the present
posthoc analysis. Oversizing was determined as percent perimeter
oversizing ({THV perimeter/annulus perimeter-1} x100) and percent
area oversizing ({THV area/annulus area-1} x100). Patients were
divided into a moderate oversizing group(upto 20% area oversizing or
upto 9.5% perimeter oversizing) and a large oversizing group (>20%
area or 9.5% perimeter oversizing). Comparison of periprocedural and
1 year clinical outcomes for both device types were performed.
RESULTS There were 129 patients in the large oversizing group(-
BE,n¼51;SE,n¼78) and 49 in the moderate oversizing group(-
BE,n¼39;SE,n¼10). In the moderate oversizing group, device success
occurred in 36(92.3%) of the BE patients as compared to 5(50%) in the SE
group(p¼0.005). In the large oversizing group, device success occurred in
50(98%) of the BE patients as compared to 64(82.1%) for SE
group(p¼0.005). More thanmild aortic regurgitation (AR) by angiographic
core lab assessment occurredmore commonlywith SE valve implantations
in both oversizing groups (30% vs 7.7%,p¼0.09 for moderate oversiz-
ing;14% vs 2%,p¼0.03 for large oversizing). The need for a second valve
was signiﬁcantly higher for SE device in the moderate oversizing group
(30% vs none;p¼0.007). There was no annulus rupture or immediate
mortality in either group.Need for permanentpacemakerwashigher for SE
valve patients in the moderate oversizing group (55.6% vs17.6%;p¼0.03).
At 1 year, no BE valve patient had more than mild AR, which occurred
respectively in 50% and 12.7% of themoderate and large oversizing groups
of SE THV implantations.There were no signiﬁcant differences between
the devices with regard to cumulative mortality, stroke rate and rates of
hospitalizations at 1 year in the two groups.
CONCLUSIONS The BE TAVR group had less periprocedural and 1 year
rates of AR as well as higher device success rate as compared to the SE
valve group irrespective of the degree of oversizing. For SE valves,
device success was higher in the large oversized group as compared to
the moderate one. These ﬁndings underscore the importance of sig-
niﬁcant device oversizing with the SE valve.
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disease (CAD) in patients referred to trans-catheter aortic valve
replacement (TAVR) has been demonstrated by multiple large studies.
Whereas computer tomography angiography (CTA) is becoming an
indispensable component of TAVR work up, CAD assessment by CTA
has been challenging in patients undergoing TAVR due to the heavy
calciﬁcation burden and beta blockers use restrictions. Computed
fractional ﬂow reserve (FFR CT) has been shown to improve diag-
nostic accuracy and discrimination compared to CTA alone for the
diagnosis of hemodynamically signiﬁcant coronary artery disease
when compared to invasive FFR. However, its performance in TAVR
population is still unknown. The goal of this study is to determine the
incremental beneﬁt and to assess the diagnostic ability of FFR CT
derived from CTA for CAD assessment in patients referred to TAVR
over CTA alone as compared to invasive coronary angiography (ICA).
METHODS A total of 19 consecutive CTA exams with at least one non
diagnostic major coronary segment due to calcium presence were pro-
cessed by HeartFlow, Inc. to compute FFR CT. The major coronary artery
branches were divided in 10 segments per patient, and when deemed
visually interpretable and categorized in binomial fashion as non-signif-
icant or signiﬁcant coronary disease using 50% cutoff value. Results were
then compared to ICA results that were graded by different expert in
similar fashion using more than 70% stenosis for signiﬁcant disease.
Figure 1: (A) CTA showing uninterpretable LM and proximal LAD seg-
ments due to calciﬁcation blooming. (B) FFR CT of the same segments
quantiﬁed from the same set of CTA images is interpretable, revealing
normal values of 0.96 and 0.83, respectively. (C) ICA demonstrates
normal LM and mild stenosis of the proximal portion of the LAD.
RESULTS At patient level, out of the 19 cases, 11 (58%) were found
interpretable by HeartFlow and 8 (42%) uninterpretable for FFR CT
analysis. At segment level analysis of the 11 interpretable cases, the
sensitivity and speciﬁcity of FFR CT compared to ICA were 100% and
90%, respectively.
CONCLUSIONS FFR CT analysis can enhance CTA diagnostic ability to
rule out signiﬁcant CAD while maintaining high sensitivity. If these
ﬁndings are reproducible in larger series, a signiﬁcant percent of
TAVR candidates would be spared from unnecessary ICA.
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BACKGROUND The Direct Flow Medical transcatheter aortic valve
system has a non-metallic design with a pressurized supportstructure, which allows precise positioning, retrieval and full hemo-
dynamic assessment of valve performance prior to permanent im-
plantation. The Direct Flow Italian registry is a nationwide registry
enrolling patients treated with the Direct Flow Device in the aortic
position since early 2012 to evaluate outcomes of the device in a real
world setting.
METHODS A group of 142 consecutive patients treated after February
2012 in 5 Italian centers has been enrolled in the registry.
RESULTS Mean age was 82.86.1 years, mean EuroSCORE was
20.415.3%. Patient comorbidities were: COPD in 27.8%; moderate or
severe kidney disease in 31%; peripheral vessel disease in 33.3%;
previous MI in 19.1%, previous CABG in 17.0%; 67.9% of patients were
in class NYHA 3 or 4. At a median follow up of 11.2 (IQR 3.0-19.0)
months, 9.2% of patient died and the stroke rate was 2.1%. PM rate
within 30 days of the procedure was 12.7%. Vascular complications
occurred in 2.1%, conversion to cardiac surgery in 1.4% and the Direct
Flow device was retrieved to switch to a different valve in 2.1% of
patients. A procedural learning curve was apparent and mean ﬂuo-
roscopy times signiﬁcantly decreased with greater operator experi-
ence from 45.422.8 to 29.68.6 minutes when comparing the ﬁrst
and fourth quartiles (p¼0.02). Moderate or severe PV leak at the last
available echo at a median follow up of more than 11 months was
present in only 2.1% of cases.
CONCLUSIONS The Direct Flow Medical transcatheter aortic valve
system demonstrates excellent real-world outcomes in high-risk pa-
tients with severe aortic stenosis, with an overall low death stroke and
pacemaker rate and a good valve performance.
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BACKGROUND A considerable proportion of potential TAVR candi-
dates have challenging vascular anatomies that is unsuitable for
transfemoral TAVR. Transcarotid TAVR access may be an option for
these patients.
METHODS The French Transcarotid TAVR Registry is a voluntary
database that has prospectively collected patient demographics,
clinical and procedural characteristics, and clinical outcomes on pa-
tients undergoing transcarotid TAVR since 2009. All patients under-
went pre-operative multimodal imaging assessment, including
multislice computed tomography and cerebral magnetic resonance
angiography. All outcomes are reported according to the updated
Valve Academic Research Consortium.
RESULTS Among 96 patients undergoing transcarotid TAVR in France
at 3 sites between April 2009 and December 2013, the mean age was
79.49.2 years and the average STS PROM score was 7.14.1%. Suc-
cessful carotid artery access was achieved in all patients. The Med-
tronic CoreValve and Edwards SAPIEN THV were implanted in 89
(92.7%) and 7 (7.3%) patients, respectively. Procedural complications
included: THV embolization (3.1%); implantation of a second THV
(3.1%); and cardiac tamponade due to left ventricular wire perforation
(4.2%). There were no major bleeds or major vascular complications
related to the carotid access site. There were 3 (3.1%) procedural
deaths and 6 deaths (6.3%) at 30-days. There were 3 (3.1%) cases of
VARC-deﬁned in-hospital stroke (n¼0) or TIA (n¼3). No patient ach-
ieved the criteria for stroke and none had new ischemic lesions on
neuroimaging. At 30-days, a further 3 TIAs were observed, giving an
overall stroke/TIA rate of 6.3%.
CONCLUSIONS Transcarotid vascular access for TAVR is feasible and
is associated with encouraging short and medium-term clinical out-
comes. Prospective studies are required to ascertain if transcarotid
TAVR yields equivalent safety and efﬁcacy to other non-femoral
vascular access routes.
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